Doctor profile · Federal record
Dr. Daniel Learned, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Ophthalmology Physician · Santa Barbara, CA
- NPI 1033406780
- Accepts Medicare
- 15 yrs in practice
- Licensed in 3 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
525 E Micheltorena St Ste A
Santa Barbara, CA 931034211
(805) 963-1648
fax (805) 965-5214
Credentials & registration
- NPI registered
- July 2011 — 15 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (3)
- California #A146139 · Michigan #4301099094 · Massachusetts #262169
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1033406780. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
40,072
Distinct HCPCS
10
Medicare allowed
$6,452,768
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 18,900 | 70 | $36 | |
92134 |
Imaging of retina | 3,924 | 1,450 | $44 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,646 | 178 | $276 | |
J0178 |
Injection, aflibercept, 1 mg | 3,162 | 280 | $861 | |
67028 |
Injection of drug into eye | 2,569 | 569 | $140 | |
92014 |
Established patient complete exam of visual system | 2,245 | 1,178 | $137 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 1,353 | 63 | $225 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 1,046 | 743 | $16 | |
92012 |
Established patient problem focused exam of visual system | 924 | 582 | $97 | |
92250 |
Photography of the retina | 463 | 412 | $39 |
In context: peer comparison
Among 5 peers in Santa Barbara Retina Specialist (Ophthalmology) Physician, average services per provider: 1,545. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$9,485
Transactions
36
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | 13 | $8,787.23 | |
| Genentech USA, INC. | 6 | $175.21 | |
| Regeneron Healthcare Solutions, INC. | 5 | $174.07 | |
| Apellis Pharmaceuticals, INC. | 5 | $151.18 | |
| Abbvie INC. | 4 | $110.03 | |
| Boston Scientific Corporation | 1 | $36.99 | |
| Astellas Pharma US INC | 1 | $27.17 | |
| Alimera Sciences, INC. | 1 | $23.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
864
Patients
448
Total drug cost
$35,606
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 189 | 105 | $7,739 |
| Latanoprost | Generic | 131 | 39 | $1,818 |
| Erythromycin (Erythromycin Base) | Brand | 120 | 76 | $1,234 |
| Atropine Sulfate | Generic | 83 | 64 | $4,324 |
| Brimonidine Tartrate | Generic | 81 | 26 | $1,793 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 62 | 37 | $1,971 |
| Ketorolac Tromethamine | Generic | 61 | 31 | $1,672 |
| Ciprofloxacin Hcl | Generic | 49 | 44 | $734 |
| Ofloxacin | Generic | 31 | 26 | $428 |
| Timolol Maleate | Generic | 16 | 0 | $173 |
Frequently asked questions
What is Dr. Daniel Learned's medical specialty?
Dr. Daniel Learned practices Retina Specialist (Ophthalmology) Physician in Santa Barbara, CA.
Where does Dr. Daniel Learned practice?
Dr. Daniel Learned practices at 525 E Micheltorena St Ste A, Santa Barbara, CA 931034211. Office phone: 8059631648.
What is Dr. Daniel Learned's NPI?
Dr. Daniel Learned's National Provider Identifier (NPI) is 1033406780, issued by NPPES.
Does Dr. Daniel Learned accept Medicare assignment?
Yes. Dr. Daniel Learned accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Learned commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg (HCPCS Q5128). Source: CMS Medicare Physician & Other Practitioners file.